comparemela.com

Page 3 - Richard Armer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Redx Pharma plc Announcements | Redx Pharma plc: Encouraging Data on Porcupine and ROCK Inhibitors

Investegate announcements from Redx Pharma plc, Encouraging Data on Porcupine and ROCK Inhibitors

Cholla namdoSouth koreaUnited kingdomAlderley parkBorough of cheshire eastMarina pajicSimon conway ciara martinDebby laukensCaitlin pearsonEli lillyMatt davis adam dawesSatheesh nadarajah david wilsonRedx pharmaRichard armerLisa ansonPeter bunyard

Redx Pharma PLC says data supports use of Porcupine and ROCK inhibitors as potential treatments for cancer-associated fibrosis

Redx Pharma PLC (AIM:REDX) said it presented encouraging data at an event in Copenhagen that supported its Porcupine and ROCK inhibitors as potential novel.

Marina pajicRichard armerPeter bunyardGarvan institute of medical researchBelgium ghent universityExtracellular matrix pharmacology congressRedx pharmaProfessor marina pajicGarvan instituteMedical researchGhent university

Investegate |Redx Pharma plc Announcements | Redx Pharma plc: Admission of Placing Shares

Investegate announcements from Redx Pharma plc, Admission of Placing Shares

United statesFrance generalUnited kingdomAlderley parkBorough of cheshire eastSimon conway ciara martinCaitlin pearsonJames meadClaire solkEli lillyMatt davis adam dawesSatheesh nadarajah david wilsonRedx pharmaJane robertsonRichard armerLisa anson

Investegate |Redx Pharma plc Announcements | Redx Pharma plc: New Grant of Options

Investegate announcements from Redx Pharma plc, New Grant of Options

Alderley parkBorough of cheshire eastUnited kingdomSimon conway ciara martinCaitlin pearsonJames meadClaire solkEli lillyMatt davis adam dawesSatheesh nadarajah david wilsonRedx pharmaJane robertsonRichard armerLisa ansonPeter collumHead of communications

Redx Pharma Chief Scientific officer Richard Armer presents RXC007 fibrosis drug programme

Redx Pharma Plc s (LON:REDX) Chief Scientific officer Richard Armer joins Proactive London s Katie Pilbeam to recap on its RXC007 programme - a drug.

City ofUnited kingdomRichard armerKatie pilbeamRedx pharma plcChief scientificProactive londonIdiopathic pulmonary fibrosisDirector interviewsHarma biotechRedx pharma plcLon redxநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்ரிச்சர்ட் கவசம்தலைமை அறிவியல்

vimarsana © 2020. All Rights Reserved.